home / stock / axsm / axsm articles

AXSM Articles, Axsome Therapeutics Inc. - From 11/21/23

Stock Information
Company Name: Axsome Therapeutics Inc.
Stock Symbol: AXSM
Market: NASDAQ
Website: axsome.com
Menu
AXSM AXSM Quote AXSM Short AXSM News AXSM Articles AXSM Message Board
Get AXSM Alerts

News, Short Squeeze, Breakout and More Instantly...
Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference | Benzinga

NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors to Secure Counsel Before Important December 7 Deadline in Securities Class Action – AXSM | Benzinga

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the reopening of the lead plainti...

Axsome's Strategy on Payer Coverage Slowly Pays Off, Depression Drug Sales Show Growth | Benzinga

Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q3 revenues of $57.8 million, up 244% Y/Y, beating the consensus of $54.75 million. Auvel...

Axsome Therapeutics to Present at Upcoming Investor Conferences | Benzinga

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel...
Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer's Disease Agitation at the Clinical Trials on Alzheimer's Disease (CTAD) 2023 Conference | Benzinga

NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel...

Axsome Therapeutics Director Awarded $487K Worth of Stock Options | Benzinga

Susan Mahony, Director at Axsome Therapeutics (NASDAQ:AXSM), reported a large acquisition of company stock options on October 13, according to a ne...

Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors | Benzinga

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel...
Axsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness Week | Benzinga

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel...

Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day | Benzinga

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering nove...

Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023 | Benzinga

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness assoc...
Previous 10 Next 10